drugset / Trial / NCT01360970
Hepatitis A Vaccine in Patients With Immunomodulating Drugs
NaSingle-groupOpen-labelPrevention
Summary
Hepatitis A vaccine is the most frequently used traveller's vaccine, yet data on its ability to induce protective immunity in immunosuppressed travellers are scarce. The investigators assess the hepatitis A virus (HAV) antibody response in patients with rheumatoid arthritis (RA) treated with Tumor Necrosis Factor (TNF) - inhibitors and/or methotrexate (Mtx).
Timeline
- Start
- 2009-09
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epaxal | Vaccine | 0.5 ml | Intramuscular |
| Subject | Havrix | Vaccine | 1 ml | Intramuscular |
Indications
No indication recorded.